New Delhi, Nov. 11 -- The initial public offering (IPO) of agrochemical player Mahamaya Lifesciences opened for public subscription on Tuesday, November 11. The SME IPO is a book build issue of Rs.70.44 crore and is a combination of a fresh issue of 56,38,800 shares and an offer for sale (OFS) of 5,40,000 shares. Meanwhile, as per grey market sources, investors are not expressing significant optimism about the BSE SME IPO, as the latest grey market premium (GMP) of the Mahamaya Lifesciences IPO was nil.

By 11:10 am on Tuesday, the SME IPO had seen an overall subscription of 2 per cent, with the retail portion booked at 3 per cent. The segments reserved for NIIs and QIBS were yet to see any subscription.

1. Mahamaya Lifesciences IPO GMP:...